Recent: Hearing on the pharmaceutical industry in the United States

RFK Jr.'s accusation towards Elizabeth Warren regarding her alleged acceptance of funds from the pharmaceutical industry elicited a strong rebuttal from Bernie Sanders. Sanders took issue with the implication that dissenting institutions are inherently corrupt due to their disagreements with RFK's views.

RFK's response emphasized that while he engages with individuals who hold opposing views, such as Jay Bhattacharya and Dr. Oz, his main concern is with the broader influence of pharmaceutical money in politics and how it may affect public trust in these institutions. He highlighted that his criticism extends to both Republicans and Democrats, including President Trump, who have all received significant campaign contributions from the industry.

Furthermore, RFK clarified that he did not claim the entire industry supported his campaign, but rather critiqued the industry's influence on political campaigns and the potential conflicts of interest it creates. The conversation underscores the importance of campaign financing transparency and the need to address the impact of special interest funding on policy-making and public trust in institutions like the American Medical Association.
Watch video:
https://youtu.be/Iwup5lCk3yg?si=B_2L8lQ9QipqEs7K